Legal & General Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-46,877
| Closed | -$844K | – | 3467 |
|
|
2020
Q2 | $844K | Buy |
46,877
+7,496
| +19% | +$104K | ﹤0.01% | 2030 |
|
|
2020
Q1 | $281K | Sell |
39,381
-3,592
| -8% | -$44.8K | ﹤0.01% | 2215 |
|
|
2019
Q4 | $1.03M | Buy |
42,973
+3,345
| +8% | +$92.3K | ﹤0.01% | 2061 |
|
|
2019
Q3 | $1.06M | Buy |
39,628
+3,676
| +10% | +$103K | ﹤0.01% | 1967 |
|
|
2019
Q2 | $975K | Buy |
35,952
+9,278
| +35% | +$291K | ﹤0.01% | 1957 |
|
|
2019
Q1 | $925K | Buy |
26,674
+1,455
| +6% | +$42K | ﹤0.01% | 1986 |
|
|
2018
Q4 | $492K | Buy |
25,219
+1,062
| +4% | +$21.8K | ﹤0.01% | 2121 |
|
|
2018
Q3 | $644K | Buy |
24,157
+3,284
| +16% | +$107K | ﹤0.01% | 2078 |
|
|
2018
Q2 | $789K | Sell |
20,873
-96
| -0.5% | -$3.67K | ﹤0.01% | 1992 |
|
|
2018
Q1 | $684K | Sell |
20,969
-3,615
| -15% | -$159K | ﹤0.01% | 2030 |
|
|
2017
Q4 | $1.19M | Buy |
24,584
+2,120
| +9% | +$107K | ﹤0.01% | 1826 |
|
|
2017
Q3 | $1.21M | Buy |
22,464
+3,594
| +19% | +$211K | ﹤0.01% | 1785 |
|
|
2017
Q2 | $1.06M | Buy |
18,870
+506
| +3% | +$20.3K | ﹤0.01% | 1802 |
|
|
2017
Q1 | $719K | Buy |
18,364
+290
| +2% | +$9.24K | ﹤0.01% | 1917 |
|
|
2016
Q4 | $404K | Buy |
18,074
+4,958
| +38% | +$96.9K | ﹤0.01% | 2032 |
|
|
2016
Q3 | $297K | Sell |
13,116
-374
| -3% | -$8.78K | ﹤0.01% | 1922 |
|
|
2016
Q2 | $320K | Hold |
13,490
| – | – | ﹤0.01% | 1580 |
|
|
2016
Q1 | $277K | Buy |
13,490
+4,263
| +46% | +$135K | ﹤0.01% | 1611 |
|
|
2015
Q4 | $475K | Hold |
9,227
| – | – | ﹤0.01% | 1343 |
|
|
2015
Q3 | $395K | Buy |
9,227
+606
| +7% | +$29.2K | ﹤0.01% | 1368 |
|
|
2015
Q2 | $383K | Buy |
8,621
+1,888
| +28% | +$76K | ﹤0.01% | 1411 |
|
|
2015
Q1 | $260K | Buy |
6,733
+1,309
| +24% | +$45K | ﹤0.01% | 1566 |
|
|
2014
Q4 | $158K | Hold |
5,424
| – | – | ﹤0.01% | 1710 |
|
|
2014
Q3 | $140K | Buy |
+5,424
| New | +$143K | ﹤0.01% | 1692 |
|
Legal & General Group's PTLA Position: Q3 2020 in Review
Legal & General Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 46,877 shares — an estimated $844K sold.
Legal & General Group first reported a position in PTLA in Q3 2014 and held it in 24 quarters. The position peaked at $1.21M in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Legal & General Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Legal & General Group sold 46,877 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $844K.
- Legal & General Group first reported a position in Portola Pharmaceuticals, Inc. in Q3 2014 and held it in 24 quarters.
- Legal & General Group's Portola Pharmaceuticals, Inc. position peaked at $1.21M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Legal & General Group's 13F filing for Q3 2020, filed 13 Nov 2020.